PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Insights+: EMA Marketing Authorization of New Drugs in August 2022

Insights+: EMA Marketing Authorization of New Drugs in August 2022

September 28, 2022

Harrow and Sintetica Receives the US FDA’s Approval for Iheezo (chloroprocaine hydrochloride ophthalmic gel) to Treat Ocular Surface Anesthesia

Harrow and Sintetica Receives the US FDA’s Approval for Iheezo (chloroprocaine hydrochloride ophthalmic gel) to Treat Ocular Surfa...

September 28, 2022

Celltrion’s Vegzelma (biosimilar, bevacizumab) Receives the US FDA’s Approval for the Treatment of Cancers

Celltrion’s Vegzelma (biosimilar, bevacizumab) Receives the US FDA’s Approval for the Treatment of Cancers

September 28, 2022

BioArctic Partner Eisai Reports P-III (Clarity AD) Study Results of Lecanemab for the Treatment of Alzheimer's Disease

BioArctic Partner Eisai Reports P-III (Clarity AD) Study Results of Lecanemab for the Treatment of Alzheimer's Disease

September 28, 2022

Avidity Biosciences Reports the US FDA's Clinical Hold on P-I/II (MARINA) Trial of AOC 1001 for Myotonic Dystrophy Type 1

Avidity Biosciences Reports the US FDA's Clinical Hold on P-I/II (MARINA) Trial of AOC 1001 for Myotonic Dystrophy Type 1

September 28, 2022

Arsenal Entered into a Multi-Year Collaboration with Genentech to Identify T-Cell Therapies for Cancer

Arsenal Entered into a Multi-Year Collaboration with Genentech to Identify T-Cell Therapies for Cancer

September 28, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us